• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Access to medicines versus access to treatment: the case of type 1 diabetes.

作者信息

Beran David, McCabe Ariane, Yudkin John S

机构信息

International Insulin Foundation, London, England.

出版信息

Bull World Health Organ. 2008 Aug;86(8):648-9. doi: 10.2471/blt.07.048710.

DOI:10.2471/blt.07.048710
PMID:18797626
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2649458/
Abstract
摘要

相似文献

1
Access to medicines versus access to treatment: the case of type 1 diabetes.药品可及性与治疗可及性：1型糖尿病的案例
Bull World Health Organ. 2008 Aug;86(8):648-9. doi: 10.2471/blt.07.048710.
2
TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.《与贸易有关的知识产权协定》、药品专利与基本药物的获取：从西雅图到多哈的漫长之路
Chic J Int Law. 2002 Spring;3(1):27-46.
3
On the road to the insulin centenary.在通往胰岛素百年诞辰的道路上。
Lancet. 2012 Nov 10;380(9854):1648. doi: 10.1016/S0140-6736(12)61950-3.
4
Innovation and the WHO's essential medicines list: giving credit where credit is due.创新与世界卫生组织基本药物清单：该归功之处归功于人。
Res Social Adm Pharm. 2007 Mar;3(1):137-44. doi: 10.1016/j.sapharm.2006.05.006.
5
Access to essential medications for HIV/AIDS in South Africa.南非艾滋病毒/艾滋病基本药物的获取情况。
S Afr Med J. 2001 May;91(5):384-7.
6
Insulin for all: treatment activism and the global diabetes crisis.全民胰岛素：治疗行动主义与全球糖尿病危机
Lancet. 2019 May 25;393(10186):2116-2117. doi: 10.1016/S0140-6736(19)31090-6.
7
Access denied to essential medicines in developing world.发展中世界获取基本药物受限。
Lancet Infect Dis. 2002 Dec;2(12):711. doi: 10.1016/s1473-3099(02)00466-8.
8
Improving access to medicines in poor countries: the role of universities.改善贫困国家的药品可及性：大学的作用。
PLoS Med. 2006 Apr;3(6):e136. doi: 10.1371/journal.pmed.0030136.
9
Access to Cardiovascular Disease and Hypertension Medicines in Developing Countries: An Analysis of Essential Medicine Lists, Price, Availability, and Affordability.发展中国家心血管疾病和高血压药物的可及性：基本药物清单、价格、可获得性及可负担性分析
J Am Heart Assoc. 2020 May 5;9(9):e015302. doi: 10.1161/JAHA.119.015302. Epub 2020 Apr 25.
10
Access to essential drugs, human rights and global justice.基本药物的可及性、人权与全球正义。
Monash Bioeth Rev. 2004 Jan;23(1):S56-74.

引用本文的文献

1
Diabetes self-management: a qualitative study of education needs, practices and caregiver support in the Keta Municipality of Ghana.糖尿病自我管理：加纳凯塔市教育需求、实践及照护者支持的质性研究
BMJ Public Health. 2024 Aug 14;2(2):e000640. doi: 10.1136/bmjph-2023-000640. eCollection 2024 Dec.
2
Barriers and Facilitators in Access to Diabetes, Hypertension, and Dyslipidemia Medicines: A Scoping Review.糖尿病、高血压和血脂异常药物获取的障碍与促进因素：一项范围综述
Public Health Rev. 2022 Sep 2;43:1604796. doi: 10.3389/phrs.2022.1604796. eCollection 2022.
3
Optimizing diabetes mellitus care to improve COVID-19 outcomes in resource-limited settings in Africa.在非洲资源有限的环境中优化糖尿病护理以改善COVID-19治疗结果。
Ther Adv Infect Dis. 2021 Apr 26;8:20499361211009380. doi: 10.1177/20499361211009380. eCollection 2021 Jan-Dec.
4
Mitigating The Burden Of Diabetes In Sub-Saharan Africa Through An Integrated Diagonal Health Systems Approach.通过综合对角卫生系统方法减轻撒哈拉以南非洲地区的糖尿病负担。
Diabetes Metab Syndr Obes. 2019 Oct 31;12:2261-2272. doi: 10.2147/DMSO.S207427. eCollection 2019.
5
Ensuring Patient-Centered Access to Cardiovascular Disease Medicines in Low-Income and Middle-Income Countries Through Health-System Strengthening.通过加强卫生系统确保低收入和中等收入国家以患者为中心获得心血管疾病药物。
Cardiol Clin. 2017 Feb;35(1):125-134. doi: 10.1016/j.ccl.2016.08.008.
6
Managing non-communicable diseases at health district level in Cambodia: a systems analysis and suggestions for improvement.柬埔寨卫生区层面的非传染性疾病管理：系统分析与改进建议
BMC Health Serv Res. 2016 Jan 27;16:32. doi: 10.1186/s12913-016-1286-9.
7
Health systems research for policy change: lessons from the implementation of rapid assessment protocols for diabetes in low- and middle-income settings.促进政策变革的卫生系统研究：低收入和中等收入环境中糖尿病快速评估方案实施的经验教训。
Health Res Policy Syst. 2015 Oct 1;13:41. doi: 10.1186/s12961-015-0029-4.
8
Low utilisation of diabetes medicines in Iran, despite their affordability (2000-2012): a time-series and benchmarking study.伊朗糖尿病药物利用率低，尽管其价格可承受（2000 - 2012年）：一项时间序列和基准研究。
BMJ Open. 2014 Oct 16;4(10):e005859. doi: 10.1136/bmjopen-2014-005859.
9
Selection of essential medicines for diabetes in low and middle income countries: a survey of 32 national essential medicines lists.低收入和中等收入国家糖尿病基本药物的选择：对32份国家基本药物清单的调查
PLoS One. 2014 Sep 26;9(9):e106072. doi: 10.1371/journal.pone.0106072. eCollection 2014.
10
Patent and exclusivity status of essential medicines for non-communicable disease.非传染性疾病基本药物的专利和专有权状况。
PLoS One. 2012;7(11):e51022. doi: 10.1371/journal.pone.0051022. Epub 2012 Nov 30.

本文引用的文献

1
The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries.六个低收入和中等收入国家中某些慢性病基本药物的可获得性和可负担性。
Bull World Health Organ. 2007 Apr;85(4):279-88. doi: 10.2471/blt.06.033647.
2
Diabetes care in sub-Saharan Africa.撒哈拉以南非洲地区的糖尿病护理
Lancet. 2006 Nov 11;368(9548):1689-95. doi: 10.1016/S0140-6736(06)69704-3.
3
Assessing health systems for type 1 diabetes in sub-Saharan Africa: developing a 'Rapid Assessment Protocol for Insulin Access'.评估撒哈拉以南非洲地区的1型糖尿病医疗系统：制定“胰岛素获取快速评估方案”
BMC Health Serv Res. 2006 Feb 24;6:17. doi: 10.1186/1472-6963-6-17.
4
Access to care for patients with insulin-requiring diabetes in developing countries: case studies of Mozambique and Zambia.发展中国家胰岛素依赖型糖尿病患者的医疗服务可及性：莫桑比克和赞比亚的案例研究
Diabetes Care. 2005 Sep;28(9):2136-40. doi: 10.2337/diacare.28.9.2136.
5
Regional patterns of disability-free life expectancy and disability-adjusted life expectancy: global Burden of Disease Study.无残疾预期寿命和伤残调整生命年的区域模式：全球疾病负担研究
Lancet. 1997 May 10;349(9062):1347-52. doi: 10.1016/S0140-6736(96)07494-6.